Dr. Kreiter has more than 20 years of academic and industry experience designing and conducting epidemiological studies and clinical trials in degenerative dementias (e.g., Alzheimer’s Disease, Parkinsons, etc), cerebrovascular disorders (e.g., hemorrhagic stroke, ischemic stroke), and multiple sclerosis. Kurt is currently the Senior Director of Medical Affairs at SAGE Therapeutics and was formerly the Senior Director of Global Medical Affairs for Biogen Idec. His specific expertise in information governance and knowledge management, neuropsychology, patient reported outcomes and quality of life helped prepare him for IND submissions, product launches and drug development. He earned a BSc in Psychology from the University of Houston, TX, and a Ph.D. in Neuropsychology from the City University of New York. Kurt completed his post-doctoral work at Columbia University, which led to an Assistant Professor appointment to study the neuropsychological impact of acute brain injuries.